Italia markets closed
  • FTSE MIB

    22.381,35
    -256,37 (-1,13%)
     
  • Dow Jones

    30.814,26
    -177,26 (-0,57%)
     
  • Nasdaq

    12.998,50
    -114,14 (-0,87%)
     
  • Nikkei 225

    28.519,18
    -179,08 (-0,62%)
     
  • Petrolio

    52,04
    -1,53 (-2,86%)
     
  • BTC-EUR

    30.819,13
    +173,58 (+0,57%)
     
  • CMC Crypto 200

    701,93
    -33,21 (-4,52%)
     
  • Oro

    1.827,70
    -23,70 (-1,28%)
     
  • EUR/USD

    1,2085
    -0,0071 (-0,58%)
     
  • S&P 500

    3.768,25
    -27,29 (-0,72%)
     
  • HANG SENG

    28.573,86
    +77,00 (+0,27%)
     
  • Euro Stoxx 50

    3.599,55
    -41,82 (-1,15%)
     
  • EUR/GBP

    0,8887
    +0,0010 (+0,11%)
     
  • EUR/CHF

    1,0759
    -0,0034 (-0,32%)
     
  • EUR/CAD

    1,5369
    +0,0008 (+0,05%)
     

Global Bone Cancer Drugs Market to Grow by $911.76 Million During 2020-2024 | Growing Risk Factors to Emerge as Key Driver | Technavio

·4 minuto per la lettura

The bone cancer drugs market is poised to grow by USD 911.76 million during 2020-2024, progressing at a CAGR of over 5% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005596/en/

Technavio has announced its latest market research report titled Global Bone Cancer Drugs Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the bone cancer drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by growing risk factors.

The bone cancer drugs market analysis includes the indication and geography landscape. This study identifies the advent of targeted therapies as one of the prime reasons driving the bone cancer drugs market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The bone cancer drugs market covers the following areas:

Bone Cancer Drugs Market Sizing

Bone Cancer Drugs Market Forecast

Bone Cancer Drugs Market Analysis

Companies Mentioned

  • Amgen Inc.

  • Baxter International Inc.

  • Bayer AG

  • Bristol-Myers Squibb Co.

  • Eisai Co. Ltd.

  • F. Hoffmann-La Roche Ltd.

  • Merck & Co. Inc.

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

Related Reports on Health Care Include:

Global Cancer Supportive Care Market - Global cancer supportive care market is segmented by therapeutic area (chemotherapy-induced anemia, chemotherapy-induced neutropenia, cancer pain, CINV, and others) and geography (APAC, Europe, MEA, North America, and South America). Click Here to Get an Exclusive Free Sample Report

Global Cervical Cancer Therapeutics Market - Global cervical cancer therapeutics market is segmented by type (drugs and vaccines) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Indication

  • Market segments

  • Comparison by indication

  • Osteosarcoma - Market size and forecast 2019-2024

  • Ewing's sarcoma - Market size and forecast 2019-2024

  • Chondrosarcoma - Market size and forecast 2019-2024

  • Other bone cancers - Market size and forecast 2019-2024

  • Market opportunity by Indication

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Vendor landscape

  • Landscape disruption

  • Competitive Scenario

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Amgen Inc.

  • Baxter International Inc.

  • Bayer AG

  • Bristol-Myers Squibb Co.

  • Eisai Co. Ltd.

  • F. Hoffmann-La Roche Ltd.

  • Merck & Co. Inc.

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005596/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/